Guided Therapeutics (GTHP) Preferred Shares (2013 - 2026)
Guided Therapeutics (GTHP) posted Preferred Shares of $284000.0 for Q4 2025, up 365.57% sequentially from $61000.0 in Q2 2025, and up 67.06% YoY from $170000.0 in Q4 2024.
Guided Therapeutics (GTHP) Preferred Shares (2013 - 2026) Analysis & Trends
Guided Therapeutics has reported Preferred Shares for 11 years, with the latest figure at $284000.0 in Q4 2025.
- Quarterly Preferred Shares rose 67.06% year-over-year to $284000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $284000.0 (up 67.06% YoY) and the FY2025 annual result came in at $284000.0, up 67.06% from the prior year.
- Preferred Shares advanced to $284000.0 in Q4 2025 per GTHP's latest filing, from $61000.0 in the prior quarter.
- Over five years, Preferred Shares peaked at $892000.0 in Q3 2022 and troughed at $32000.0 in Q1 2025.
- A 5-year average of $322894.7 and a median of $170000.0 in 2021 frame the typical range for Preferred Shares.
- The sharpest annual moves came in 2022 and 2025: Preferred Shares surged 424.71% in 2022, then plunged 96.16% in 2025.
- Over 5 years, Preferred Shares stood at $531000.0 in 2021, then plunged by 80.23% to $105000.0 in 2022, then jumped by 61.9% to $170000.0 in 2023, then changed by 0.0% to $170000.0 in 2024, then soared by 67.06% to $284000.0 in 2025.
- According to Business Quant data, Preferred Shares over the past three periods registered $284000.0, $61000.0, and $32000.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | 226,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 226,000.00 |
| Dec 31, 2025 | 284,000.00 |
| Jun 30, 2025 | 61,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Dec 31, 2024 | 170,000.00 |
| Sep 30, 2024 | 105,000.00 |
| Jun 30, 2024 | 170,000.00 |
| Mar 31, 2024 | 834,000.00 |
| Dec 31, 2023 | 170,000.00 |
| Sep 30, 2023 | 159,000.00 |
| Jun 30, 2023 | 838,000.00 |
| Mar 31, 2023 | 159,000.00 |
| Dec 31, 2022 | 105,000.00 |
| Sep 30, 2022 | 892,000.00 |
| Jun 30, 2022 | 839,000.00 |
| Mar 31, 2022 | 170,000.00 |
| Dec 31, 2021 | 531,000.00 |
| Sep 30, 2021 | 170,000.00 |
| Jun 30, 2021 | 276,000.00 |
| Mar 31, 2021 | 170,000.00 |